Forge commits $30 million to webAI as the companies partner to build and deploy private, specialized AI systems inside enterprises.

AUSTIN, Texas, Sept. 24, 2026 /PRNewswire/ — webAI today announced a strategic partnership with Forge AI Deployment, which is making a $30 million commitment to webAI to build and deploy private, specialized AI systems for enterprise customers.

The partnership pairs webAI’s collaborative intelligence platform with Forge’s enterprise deployment and services operation. Forge will work directly with customers to build AI systems around their proprietary data, workflows and operations, running on infrastructure those customers control.

The agreement comes as the AI market begins shifting from building increasingly capable general-purpose models to putting specialized intelligence to work inside businesses.

Forge is led by enterprise technology veterans, including founder and CEO John Ezzell, who previously built an Oracle-focused services and reseller business that was acquired by Deloitte. Forge is applying a similar playbook to AI: combining a new technology platform with the implementation, integration and operational expertise required to make it useful inside large organizations.

webAI provides the intelligence layer behind that effort.

Rather than relying solely on a general-purpose model, webAI enables organizations to deploy specialized models around their own data, people and operations. Those models can run across infrastructure the organization controls and collaborate as a system.

Forge will design, deploy and operate those systems for customers, from individual specialized AI Personas to company-wide deployments.

“A general model is only the beginning,” said David Stout, co-founder and CEO of webAI. “Individuals and organizations need intelligence deeply specialized to them. We believe the path to super intelligence (SI) isn’t one model that knows everything; it’s specialized intelligence working together. Collaboration gets us there faster.”

From AI models to AI infrastructure

webAI calls this emerging architecture the decision factory: intelligence built around the unique knowledge, expertise and workflows of an organization and deployed wherever decisions are made.

Instead of relying on a single general-purpose model, specialized AI Personas can operate as domain experts and work together across webAI’s Intelligence Delivery Network (IDN), a private network of compute controlled by the organization.

Forge will take responsibility for turning that technology into working enterprise systems, including architecture, secure deployment, model integration and optimization.

“Enterprises don’t need another AI demo,” said John Ezzell, founder and CEO of Forge AI Deployment. “They need AI that actually works inside their business. The opportunity is to take this technology from experimentation to production, and webAI gives us the infrastructure to do that.”

The partnership also expands webAI’s growing ecosystem of systems integrators, software companies and channel partners building, deploying and distributing specialized AI solutions on its platform across commercial and public-sector markets.

For enterprises, the shift is simple: AI stops being something they subscribe to and becomes intelligence they own.

About webAI
webAI is building collaborative intelligence: a private, local-first approach to AI in which specialized models run close to where work happens and collaborate with one another and the people they support. webAI enables individuals and organizations to create, own and deploy specialized intelligence across their own devices and environments. Headquartered in Austin, Texas, webAI’s mission is to make powerful AI accessible, personal and collaborative. Learn more at webai.com.

About Forge AI Deployment
Forge AI Deployment is an official webAI systems integrator that designs, installs and operates sovereign AI systems inside infrastructure customers control, including enterprise data centers, edge sites and air-gapped or disconnected enclaves. Combining more than two decades of work in high-consequence and Fortune 100 environments with webAI’s local-first platform, Forge provides end-to-end architecture, secure deployment, model integration and optimization while keeping institutional knowledge within the customer’s perimeter.

Media Contact
webAI@pinkston.co

View original content to download multimedia:https://www.prnewswire.com/news-releases/webai-lands-30-million-ai-deal-with-forge-as-enterprise-ai-services-race-accelerates-302889811.html

SOURCE webAI

WASHINGTON, Sept. 24, 2026 /PRNewswire/ — In response to a letter from U.S. Senator Elizabeth Warren (D-Mass.), state insurance regulators leading the National Association of Insurance Commissioners (NAIC) today detailed how the state-based regulatory framework is evolving alongside insurers’ changing investment strategies, ownership structures, and risk-transfer arrangements.  

“Rather than relying on a static regulatory framework, regulators have regularly updated capital requirements, reporting standards, supervisory tools, and analytical capabilities to address emerging risks while maintaining a consistent focus on insurer solvency and policyholder protection,” said NAIC leadership.

Among other actions, this work includes:

Strengthening asset-adequacy testing through Actuarial Guideline 53 (AG 53) to provide greater consistency in evaluating the risks associated with complex and higher-yielding assets supporting life insurance business.

Intensifying oversight of certain life insurance and annuity reinsurance transactions through Actuarial Guideline 55 (AG 55), including setting higher expectations for asset-adequacy analysis and reserve adequacy.

Instituting a 45% risk-based capital charge for residual interests in structured securities to ensure that capital requirements appropriately recognize investment risk.

Creating a formal process for evaluating whether credit rating providers’ methodologies and rating mappings remain appropriate for regulatory purposes.

As NAIC leaders noted, “State insurance regulators continually evaluate whether the solvency framework appropriately captures emerging and changing risks.”

This adaptive approach, built on collaboration and coordination, has enabled state-based insurance regulation to lead for more than 150 years and will continue to guide it in an ever-changing insurance landscape.

Resources

Full Letter

NAIC Resource Center: Private Credit and Insurance Regulation

State-Based Regulatory Timeline for NAIC’s Solvency Oversight

About the National Association of Insurance Commissioners

As part of our state-based system of insurance regulation in the United States, the National Association of Insurance Commissioners (NAIC) provides expertise, data, and analysis for insurance commissioners to effectively regulate the industry and protect consumers. The U.S. standard-setting organization is governed by the chief insurance regulators from the 50 states, the District of Columbia and five U.S. territories. Through the NAIC, state insurance regulators establish standards and best practices, conduct peer reviews, and coordinate regulatory oversight. NAIC staff supports these efforts and represents the collective views of state regulators domestically and internationally.

View original content to download multimedia:https://www.prnewswire.com/news-releases/naic-letter-details-proactive-state-oversight-of-evolving-insurance-landscape-302889813.html

SOURCE NATIONAL ASSOCIATION OF INSURANCE COMMISSIONERS

PUNE, India, Sept. 24, 2026 /PRNewswire/ — The Global Bioinformatics Market was valued at USD 20.34 Billion in 2025 and is projected to expand at a 13.7% CAGR from 2026 to 2034, reaching USD 64.60 Billion by 2034, according to a new analysis by Maximize Market Research.

Global Bioinformatics Market

The Global Bioinformatics Market Report 2025 provides a comprehensive analysis of market trends, genomic data generation, next-generation sequencing (NGS), bioinformatics platforms, bioinformatics services, knowledge management tools, computational biology, biological databases, technology adoption, deployment models, application areas, end-user sectors, research activities, competitive developments, and market forecasts through 2034. The market covers genomics, proteomics, transcriptomics, metabolomics, molecular phylogenetics, chemoinformatics, and other bioinformatics applications across sequencing technology, microarray technology, mass spectrometry, high-throughput screening, data mining and machine learning, and structural bioinformatics tools.

The increasing volume of genomic and biological data, growing adoption of next-generation sequencing, expansion of precision medicine, rising pharmaceutical and biotechnology R&D, increasing demand for genomic data analysis, and broader application of computational biology are supporting the growth of the global bioinformatics market. Growing adoption of bioinformatics platforms, cloud-based bioinformatics, biological databases, data mining, machine learning, and AI-enabled analytical solutions is transforming genomics, drug discovery, molecular diagnostics, personalized medicine, and life-science research. Increasing investments in genomic research, sequencing infrastructure, biotechnology, pharmaceutical R&D, and computational technologies are further expanding opportunities for bioinformatics solution providers.

Advancements in artificial intelligence, machine learning, cloud computing, high-performance computing, genomic sequencing, biological data integration, data analytics, molecular modeling, and computational drug discovery are reshaping the bioinformatics landscape. Increasing research across genomics, proteomics, transcriptomics, metabolomics, chemoinformatics, and molecular phylogenetics is creating new opportunities for pharmaceutical and biotechnology companies, academic and research institutes, healthcare providers, and agricultural biotechnology organizations. Platform development, software innovation, strategic collaborations, genomic research initiatives, technology investments, data-management capabilities, and expansion of cloud-based bioinformatics solutions are expected to accelerate innovation and strengthen the global bioinformatics market through 2034.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.maximizemarketresearch.com/request-sample/207971/ 

Global Bioinformatics Market gains momentum as rising genomic data generation, increasing adoption of next-generation sequencing, growing demand for precision medicine, rapid integration of AI and machine learning, expansion of cloud-based bioinformatics, and advances in computational biology and genomic data analytics accelerate innovation: Maximize Market Research unveils key market insights.

Global Bioinformatics Market Size & Forecast

Global Bioinformatics Market Trends & Insights

North America leads the Global Bioinformatics Market, supported by advanced pharmaceutical and biotechnology R&D, strong genomics infrastructure, high adoption of next-generation sequencing, precision medicine, and advanced bioinformatics platforms.Asia Pacific is the fastest-growing region, driven by expanding biotechnology and pharmaceutical industries, increasing genomic sequencing, healthcare digitization, investments in precision medicine, and rising adoption of cloud-based bioinformatics and computational tools.Genomics and next-generation sequencing are driving market demand, as the growing volume of genomic data increases the need for advanced sequencing analysis, biological databases, data mining, computational biology, and genomic data interpretation.AI, machine learning, and cloud computing are transforming bioinformatics, enabling faster biological data processing, predictive analytics, molecular analysis, automated workflows, drug discovery, and scalable genomic research across pharmaceutical, biotechnology, and academic institutions.Precision medicine and personalized healthcare are accelerating bioinformatics adoption, with increasing demand for pharmacogenomics, biomarker analysis, genomic diagnostics, molecular profiling, and computational approaches that support targeted therapies and data-driven drug development.

Bioinformatics Market Dynamics

Growing Genomic Data Generation and NGS Drives Market Growth

The increasing adoption of next-generation sequencing (NGS) is generating large volumes of genomic data, driving demand for bioinformatics platforms, sequencing data analysis, biological databases, and computational biology. Growing applications in genomics, precision medicine, molecular diagnostics, drug discovery, and pharmacogenomics are further supporting market growth. The declining cost of sequencing and expansion of sequencing capabilities are encouraging more research institutions, pharmaceutical companies, and biotechnology organizations to adopt advanced bioinformatics solutions. Increasing genomic research and the need for faster interpretation of complex biological datasets are also strengthening demand for computational tools.

High Infrastructure Costs and Data Security Concerns Restrain Market Growth

High costs associated with high-performance computing, specialized software, data storage, cloud infrastructure, and skilled professionals can limit bioinformatics adoption, particularly among smaller research organizations. Concerns surrounding genomic data privacy, cybersecurity, regulatory compliance, and interoperability also remain important market restraints. Managing large biological datasets requires secure and scalable infrastructure, increasing operational and technology requirements. Differences between databases and bioinformatics platforms can further create challenges in seamless data sharing and integration.

AI and Cloud-Based Bioinformatics Create Opportunities

Integration of AI, machine learning, cloud computing, data mining, predictive analytics, and automated workflows is creating new opportunities in genomic data analysis, drug discovery, biomarker identification, and molecular research. Cloud-based platforms provide scalable solutions for processing large biological datasets while reducing the need for extensive on-premise computing infrastructure. AI-driven tools can support genome interpretation, protein analysis, molecular modeling, sequence analysis, and computational drug discovery. Growing adoption of these technologies across pharmaceutical, biotechnology, healthcare, and academic research is expected to expand the application scope of bioinformatics.

Shortage of Skilled Professionals Creates Challenges

The growing complexity of genomic datasets, biological databases, sequencing technologies, computational algorithms, and analytical workflows is increasing demand for specialized bioinformatics professionals. Shortages of skilled talent with expertise across biology, computer science, statistics, data science, and molecular biology can restrict the efficient implementation of advanced solutions. Data standardization, interoperability, and integration challenges can also complicate the management of biological information across multiple platforms. These limitations may affect organizations seeking to establish large-scale bioinformatics infrastructure, genomic data analysis systems, and computational research capabilities.

Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) https://www.maximizemarketresearch.com/request-sample/207971/ 

Global Bioinformatics Market Segmentation

The Global Bioinformatics Market is segmented by Product and Services, Technology, Deployment Model, Database Type, Application, End User Sector, and Region. Increasing genomic data generation, growing adoption of next-generation sequencing, rising demand for computational biology, AI and machine learning integration, expansion of cloud-based platforms, and increasing applications in precision medicine and drug discovery are supporting market development across these segments.

North America Leads the Bioinformatics Market While Asia Pacific Emerges as a High-Growth Region

North America held the largest share of the Global Bioinformatics Market in 2025, supported by strong pharmaceutical and biotechnology R&D, advanced genomics infrastructure, high adoption of next-generation sequencing (NGS), precision medicine, and computational biology. The United States represents a major market due to its established biotechnology ecosystem, genomic research capabilities, academic institutions, and adoption of bioinformatics platforms, biological databases, AI-driven analytics, and cloud-based bioinformatics solutions. Canada and Mexico are also contributing through expanding biotechnology activities, genomic research, and healthcare digitization.

Europe represents an important market, supported by established pharmaceutical and biotechnology industries, strong research institutions, advanced healthcare infrastructure, and increasing investment in genomics, proteomics, molecular diagnostics, and personalized medicine. Germany, the United Kingdom, France, Italy, Spain, Sweden, Austria, and other European countries are witnessing increasing adoption of bioinformatics software, sequencing data analysis, biological databases, computational biology, and AI-based research tools. Growth in genomic research and precision medicine is further supporting regional development.

Asia Pacific is expected to witness the fastest growth through 2034 as biotechnology and pharmaceutical industries expand and genomic sequencing becomes more widely adopted. China, Japan, India, South Korea, Australia, and other regional markets are strengthening genomics infrastructure, precision medicine, healthcare digitization, and biotechnology R&D. Increasing investments in NGS, cloud computing, machine learning, data mining, biological databases, and computational drug discovery are creating new opportunities for bioinformatics solution providers.

Middle East & Africa is gradually developing as healthcare modernization, biotechnology investment, and genomic research activities increase. GCC countries, South Africa, Egypt, Nigeria, and other markets are investing in genetic testing, precision medicine, genomic databases, advanced healthcare infrastructure, and computational research capabilities. Growing adoption of genomic technologies and increasing interest in personalized healthcare are supporting demand for bioinformatics platforms and services.

South America is supported by expanding genomic research, pharmaceutical and biotechnology activities, molecular diagnostics, and healthcare investment. Brazil represents an important regional market, while Argentina and other countries are contributing through increasing use of genomic sequencing, biological databases, bioinformatics analytics, agricultural biotechnology, and computational biology. Improving research infrastructure and growing applications of genomics are creating additional opportunities across the region.

Leading Companies Strengthen the Bioinformatics Market Landscape

Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Waters Corporation, NeoGenomics Laboratories, PerkinElmer Inc., Seven Bridges Genomics, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific, QIAGEN N.V., Fios Genomics, Genedata AG, Dassault Systèmes BIOVIA, SOPHiA GENETICS, and BGI Genomics Co., Ltd. are among the prominent companies associated with the global bioinformatics landscape. Their activities across genomic sequencing, bioinformatics platforms, biological databases, sequencing data analysis, computational biology, AI-enabled analytics, proteomics, molecular diagnostics, and bioinformatics services are supporting technological development and market expansion.

Global Bioinformatics Market Competitive Landscape

The Global Bioinformatics Market is increasingly technology-driven, with companies focusing on AI integration, machine learning, cloud-based bioinformatics, genomic data analysis, biological databases, and computational drug discovery. Key players are competing through R&D investments, technology development, strategic collaborations, product launches, platform expansion, partnerships, acquisitions, and geographic expansion. Competition is also shaped by platform scalability, data security, interoperability, analytical capabilities, ease of integration, computational performance, and the ability to manage large biological datasets across genomics, proteomics, transcriptomics, metabolomics, chemoinformatics, and molecular phylogenetics.

Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More) https://www.maximizemarketresearch.com/market-report/bioinformatics-market/207971/ 

Bioinformatics Key Players are:

North America
1. Thermo Fisher Scientific Inc. (USA)
2. Agilent Technologies Inc. (US)
3. Illumina Inc. (US)
4. Waters Corporation (US)
5. NeoGenomics Laboratories (US)
6. Perkin Elmer Inc. (US)
7. Seven Bridges Genomics, Inc. (US)
8. Station X, Inc. (US)
9. Active Motif, Inc. (US)
10. Bio-Rad Laboratories, Inc. (US)
Europe
11. Eurofins Scientific (Luxembourg)
12. QIAGEN N.V.(Netherlands)
13. Fios Genomics (UK)
14. Source BioScience (UK)
15. Genedata AG (Switzerland)
16. Eurofins Scientific SE (Luxembourg)
17. Genomatix Software GmbH (Germany)
18. Dassault Systèmes Biovia Corp. (France)
19. Sophia Genetics SA (Switzerland)
Asia Pacific
20. BGI Genomics Co., Ltd. (China)
21. Others

Frequently Asked Questions – Global Bioinformatics Market

1. What is the size of the Global Bioinformatics Market in 2025?
The Global Bioinformatics Market was valued at approximately USD 20.34 Billion in 2025.

2. What is the expected CAGR of the Global Bioinformatics Market through 2034?
The Global Bioinformatics Market is projected to expand at a CAGR of 13.7% during 2026–2034, supported by rising genomic research, next-generation sequencing, precision medicine, and computational biology applications.

3. Which region dominates the Global Bioinformatics Market?
North America dominated the Global Bioinformatics Market in 2025, supported by advanced biotechnology and pharmaceutical research, genomic infrastructure, bioinformatics software adoption, and strong investment in precision medicine.

4. Which region is expected to grow fastest in the Global Bioinformatics Market?
Asia Pacific is expected to register the fastest growth during the forecast period, driven by expanding biotechnology and pharmaceutical industries, genomic sequencing, healthcare digitization, and increasing adoption of AI and cloud-based bioinformatics.

5. What are the major applications of bioinformatics?
Major applications include genomics, proteomics, transcriptomics, metabolomics, chemoinformatics, and molecular phylogenetics. Among these, genomics represents a major application because of increasing sequencing activity and the growing volume of genomic data requiring computational analysis.

Access Full Summary: https://www.maximizemarketresearch.com/market-report/bioinformatics-market/207971/ 

Analyst Perspective

Analysts highlight that the Global Bioinformatics Market is driven by rising genomic data generation, increasing adoption of next-generation sequencing (NGS), precision medicine, and pharmaceutical and biotechnology R&D. Growing use of AI and machine learning, cloud-based bioinformatics, biological databases, data mining, and computational biology is expanding applications across genomics, proteomics, transcriptomics, and drug discovery. However, high infrastructure costs, data security concerns, interoperability challenges, and shortage of skilled professionals remain key challenges. Increasing research in genomic sequencing, pharmacogenomics, biomarker discovery, and computational drug discovery is creating new opportunities and is expected to shape the market through 2034.

Related Reports:

Bioinformatics Services Market by Type, Specialty, End User, Application, and Region – Global Forecast to 2034

Germany Bioinformatics Market by Technology, Application, and Region – Germany Forecast to 2034

Japan Bioinformatics Market by Technology, Application, and Region – Japan Forecast to 2034

Australia Bioinformatics Market by Technology, Application, and Region – Australia Forecast to 2034

Malaysia Bioinformatics Market by Technology, Application, and Region – Malaysia Forecast to 2034

About Maximize Market Research – Global Bioinformatics Market

Maximize Market Research is a global market research and business consulting firm delivering data-driven insights across the Healthcare, Pharmaceuticals, Life Sciences, Biotechnology, and Medical Technology sectors, including the Global Bioinformatics Market. Its research helps businesses understand market trends, genomic data generation, next-generation sequencing, emerging opportunities, and competitive dynamics across bioinformatics platforms, bioinformatics services, knowledge management tools, computational biology, biological databases, and genomic data analytics.

Expertise in Bioinformatics & Computational Biology Research

With expertise in life sciences, biotechnology, healthcare, and pharmaceutical market research, Maximize Market Research provides insights into genomics, proteomics, transcriptomics, metabolomics, molecular phylogenetics, chemoinformatics, and computational drug discovery. Its research evaluates developments across AI and machine learning, cloud-based bioinformatics, sequencing technology, data mining, biological databases, precision medicine, pharmacogenomics, and genomic data analysis, helping industry stakeholders identify opportunities across the global bioinformatics ecosystem.

Contact:
Lumawant Godage
MAXIMIZE MARKET RESEARCH PVT. LTD.
+91 96073 65656
Email: sales@maximizemarketresearch.com
Content Source: https://www.maximizemarketresearch.com/market-report/bioinformatics-market/207971/
Visit Our Web Site: https://www.maximizemarketresearch.com/
LinkedIn.com: https://www.linkedin.com/company/maxmize-market-research-pvt-ltd/
Instagram: https://www.instagram.com/maximizemarketresearch/
Facebook: https://www.facebook.com/maximizemarketresearch/
X (Twitter): https://x.com/MMRAnalytics

View original content to download multimedia:https://www.prnewswire.com/news-releases/global-bioinformatics-market-to-reach-usd-64-60-billion-by-2034–driven-by-ai-genomics-next-generation-sequencing-and-precision-medicine-report-maximize-market-research-302889160.html

SOURCE Maximize Market Research Pvt. Ltd.